Inactive Instrument

Other languages Auris Medical Holding Ltd. Börse Stuttgart

Equities

2QAA

BMG070252017

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Altamira Therapeutics Provides Business Update	May. 28
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal	May. 23
Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors	May. 16
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation	May. 01
Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation	May. 01
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal	Apr. 24
Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal	Apr. 24
Altamira Therapeutics : Notice of the Annual General Meeting of Shareholders of Altamira Therapeutics Ltd. (the “Company”) to be held on May 16, 2024 - Form 6-K	Apr. 16
Transcript : Altamira Therapeutics Ltd., 2023 Earnings Call, Apr 10, 2024	Apr. 10
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results	Apr. 10
Altamira Therapeutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024	Apr. 04
Sector Update: Health Care Stocks Decline Late Afternoon	Mar. 25
Top Midday Gainers	Mar. 25
Sector Update: Health Care Stocks Softer in Afternoon Trading	Mar. 25
Altamira, Univercells Partner to Test mRNA Vaccine Delivery; Shares Surge	Mar. 25
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines	Mar. 25
Altamira Therapeutics Ltd. Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines	Mar. 25
Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal	Feb. 07
Altamira Therapeutics? Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal	Feb. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Auris Medical Holding Ltd. Börse Stuttgart

Equities

2QAA

BMG070252017

Other languages

Filters